Cimpuciclib (tosylate)
Cimpuciclib tosylate is a selective CDK4 inhibitor (IC50: 0.49 nM) that has anti-tumor activity[1].
Product Specifications
CAS Number
2408872-84-2
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
COVID-19-anti-virus
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cimpuciclib-tosylate.html
Purity
99.65
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
O=C(N1CCC(CC1)NC2CC2)C3=CC=C(NC4=NC(C5=CC6=C(N=C(C)N6C(C)C)C=C5)=C(F)C=N4)N=C3C.O=S(O)(C7=CC=C(C)C=C7)=O
Molecular Formula
C37H43FN8O4S
Molecular Weight
714.85
References & Citations
[1]Liu Shiqiang, et al. Preparation of benzimidazole compound as kinase inhibitor. Patent WO 2018045956.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK4; CDK6
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC743529-100 1x 100 µL
CD31 / PECAM-1 (Endothelial Cell Marker) (PECAM1/3529), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNCB0747-100 1x 100 µL
CD66 (CEA) (COL-1 + CEA31 + C66/261), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details